These standards, produced by the Health Protection Agency in 2011, recognise that the detection and clinical management of hepatitis B and C can involve a number of health professionals, creating a diversity of clinical pathways. The development of the standards has also taken into account the fact that the prevalence of both hepatitis B and C varies markedly across the country and that current systems for the surveillance and follow up of cases also vary.
Resources
Medical professional
Around 216,000 people in the UK are living with hepatitis C so it is important that all medical professionals have access to the latest training, information and advice on hepatitis C management. Find here links to relevant materials for clinicians, nurses, GPs, prison healthcare staff and other medical professionals.
Showing 231 to 240 of 270 resources
-
Standards for Local Surveillance and Follow Up of Hepatitis B and C
UK 2011 Reports & Research, Tools & Templates, Strategy & Planning PDF -
Greater Manchester Commissioning Guidelines for Blood Borne Virus Prevention
The burden of blood borne viruses in Greater Manchester is high. There is an upward trend in the number of HIV diagnoses in in the area and an escalation in patients attending hospitals with complications resulting from Hepatitis C. The Greater Manchester Blood Borne Virus Prevention Commissioning Guidelines are based on the Greater Manchester Blood Borne Virus Prevention Strategy. Both documents were developed by the Greater Manchester Hepatitis C Strategy (GMHCVS), a public health programme funded by the Greater Manchester Director of Public Health group.North West Mar 2011 Training, Reports & Research, Tools & Templates, Strategy & Planning PDF -
Review of the support available to individuals infected with Hepatitis C and or HIV by NHS supplied blood transfusions or blood products and their dependants
On 14 October 2010, the Government announced that it would review the support available to those who had been infected with hepatitis C and/or HIV by NHS-supplied blood transfusions or blood products. This review was conducted by the Department of Health, with input from external experts, including the Chairs of the Macfarlane and Eileen Trusts and the Skipton Fund.UK 10 Jan 2011 Reports & Research PDF -
A Census of Medical Workforce & Infrastructure for Liver Disease Strategy: Summary of Findings
As part of the National Liver Disease Strategy (NLDS), this document summarises the findings of a Census of the Medical Workforce (Consultant Gastroenterologists and Hepatologists). The census was undertaken with the aim of assessing the current capacity and infrastructure for delivery of Liver services in England, to identify which secondary care pathways already exist for referral and management, to understand how the current secondary care services relate to burden of disease, and to assess future training needs and capacity for liver services.England 2011 Reports & Research, Strategy & Planning PDF -
Tackling the problem of Hepatitis C, substance misuse and health inequalities: a Consensus for London
This document represents a call to action from experts in the fields of addiction and hepatitis in London. It provides a framework with which to address the epidemiological, clinical and financial challenges presented by current rates of hepatitis C among people who have injected drugs and sets out solutions in the form of a blueprint for local commissioners. It sets out key requirements and recommendations in terms of prevention, diagnosis, treatment and data collection for each type of service that impacts on the patient’s journey.Greater London 2011 Reports & Research, Strategy & Planning PDF -
Liver Disease Summary Statistics
This document briefly summarises the statistics for liver disease in England by prevalence, mortality and regional variation.England 2011 Reports & Research PDF -
Greater Manchester Hepatitis C Strategy: The next steps 2010 - 2013
This paper sets out the next steps for the Greater Manchester Hepatitis C Strategy (GMHCVS), which was formed in response to the national Hepatitis C Strategy in 2004 and increasing local recognition of a need to improve local services in Greater Manchester (GM). Hepatitis C is a serious public health issue for the North West and Greater Manchester in particular has consistently has the highest rates of infection in injecting drug users in the country.North West Jan 2011 Case study, Reports & Research, Strategy & Planning PDF -
Greater Manchester Blood Borne Virus Strategy
The GM Hepatitis C Strategy (GMHCVS) recognises the need for an integrated, city-wide BBV prevention strategy. To inform the BBV prevention strategy, GMHCVS has commissioned a number of needs assessments and equity audit. The aim of all the projects was to provide information on specific evidence based recommendations and identify the current gaps in service provision to inform the service redesign.North West 03 Dec 2010 Reports & Research, Strategy & Planning PDF -
Healthy Lives, Healthy People: Our strategy for public health in England
This is a new era for public health, with a higher priority and dedicated resources. This White Paper outlines the Government's commitment to protecting the population from serious health threats; helping people live longer, healthier and more fulfilling lives; and improving the health of the poorest, fastest. It responds to Professor Sir Michael Marmot’s Fair Society, Healthy Lives1 report and adopts its life course framework for tackling the wider social determinants of health.England 30 Nov 2010 Reports & Research PDF -
Treatment Guidance for Patients with Hepatitis C in Greater Manchester
This document provides guidance on treatment for patients with Hepatitis C in Greater Manchester. It defines responses to treatment, runs through treatment protocols, types of treatment for various kinds of patient, and protocols for managing treatment side effects.North West 04 Nov 2010 Reports & Research, Tools & Templates PDF